ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models.
暂无分享,去创建一个
M. Ko | S. Deaglio | F. Arruga | E. Braggio | Katti A. Jessen | L. Miller | A. Chadburn | R. Furman | A. Di Napoli | N. Vitale | J. Allan | B. Lannutti | Andrea Iannello | T. Vaisitti | K. Jessen | Th Lee | Mira Ko | Nicoletta Vitale